We would also like to point out that bladder cancer and small cell lung cancer pathways were also significant for all five methods, largely because generic oncogenes such as HRAS and FGFR3, and generic tumor suppressors such as p14ARF, p53, and Rb are identified. The gene discussed is HRAS; the disease is small cell lung carcinoma.